Management of hypertension among patients with coronary heart disease

Oladipupo Olafiranye, Ferdinand Zizi, Perry Brimah, Girardin Jean-Louis, Amgad N. Makaryus, Samy McFarlane, Gbenga Ogedegbe

Research output: Contribution to journalArticle

Abstract

Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.

Original languageEnglish (US)
Article number653903
JournalInternational Journal of Hypertension
Volume2011
DOIs
StatePublished - 2011

Fingerprint

Coronary Disease
Hypertension
Blood Pressure
Antihypertensive Agents
Myocardial Ischemia
Blood Vessels
Atherosclerosis
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Olafiranye, O., Zizi, F., Brimah, P., Jean-Louis, G., Makaryus, A. N., McFarlane, S., & Ogedegbe, G. (2011). Management of hypertension among patients with coronary heart disease. International Journal of Hypertension, 2011, [653903]. https://doi.org/10.4061/2011/653903

Management of hypertension among patients with coronary heart disease. / Olafiranye, Oladipupo; Zizi, Ferdinand; Brimah, Perry; Jean-Louis, Girardin; Makaryus, Amgad N.; McFarlane, Samy; Ogedegbe, Gbenga.

In: International Journal of Hypertension, Vol. 2011, 653903, 2011.

Research output: Contribution to journalArticle

Olafiranye, O, Zizi, F, Brimah, P, Jean-Louis, G, Makaryus, AN, McFarlane, S & Ogedegbe, G 2011, 'Management of hypertension among patients with coronary heart disease', International Journal of Hypertension, vol. 2011, 653903. https://doi.org/10.4061/2011/653903
Olafiranye O, Zizi F, Brimah P, Jean-Louis G, Makaryus AN, McFarlane S et al. Management of hypertension among patients with coronary heart disease. International Journal of Hypertension. 2011;2011. 653903. https://doi.org/10.4061/2011/653903
Olafiranye, Oladipupo ; Zizi, Ferdinand ; Brimah, Perry ; Jean-Louis, Girardin ; Makaryus, Amgad N. ; McFarlane, Samy ; Ogedegbe, Gbenga. / Management of hypertension among patients with coronary heart disease. In: International Journal of Hypertension. 2011 ; Vol. 2011.
@article{b14bda45c7a1470fa04164ba17575bc3,
title = "Management of hypertension among patients with coronary heart disease",
abstract = "Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.",
author = "Oladipupo Olafiranye and Ferdinand Zizi and Perry Brimah and Girardin Jean-Louis and Makaryus, {Amgad N.} and Samy McFarlane and Gbenga Ogedegbe",
year = "2011",
doi = "10.4061/2011/653903",
language = "English (US)",
volume = "2011",
journal = "International Journal of Hypertension",
issn = "2090-0384",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Management of hypertension among patients with coronary heart disease

AU - Olafiranye, Oladipupo

AU - Zizi, Ferdinand

AU - Brimah, Perry

AU - Jean-Louis, Girardin

AU - Makaryus, Amgad N.

AU - McFarlane, Samy

AU - Ogedegbe, Gbenga

PY - 2011

Y1 - 2011

N2 - Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.

AB - Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.

UR - http://www.scopus.com/inward/record.url?scp=80055039456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055039456&partnerID=8YFLogxK

U2 - 10.4061/2011/653903

DO - 10.4061/2011/653903

M3 - Article

VL - 2011

JO - International Journal of Hypertension

JF - International Journal of Hypertension

SN - 2090-0384

M1 - 653903

ER -